Skip to main content
$3.18 $0.16 (5.3%)

04:00 PM EDT on 05/06/21

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $3.18 Mkt Cap $137.1M
Open $3.05 P/E Ratio 0.00
Prev. Close $3.02 Div. (Yield) $0.00 (0.0%)
Daily Range $2.94 - $3.18 Volume 1,347,477
52-Wk Range $2.81 - $7.02 Avg. Daily Vol. 1,505,792

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

148 Outperform
72 Underperform
 

All-Star Players

11 Outperform
20 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (59.37)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

NYSEMKT:PLX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: +147.35

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -165.05

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (59.37) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +253.52

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (< 20) Score: +765.78

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.37 2/10/2009 Underperform 3W $2.66 +19.55% +394.33% +374.78 0 Comment
Spelunkin 23.94 11/3/2009 Underperform 5Y $10.39 -69.39% +303.96% +373.36 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -67.88% +302.45% +370.33 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -67.88% +302.45% +370.33 0 Comment
MSFOBV1YH 81.87 11/4/2009 Underperform 5Y $10.93 -70.91% +297.19% +368.09 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -73.25% +294.38% +367.64 0 Comment
ModernDayWarrior 20.21 10/29/2009 Underperform 5Y $9.58 -66.81% +298.39% +365.20 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -73.50% +288.21% +361.71 0 Comment
beecha 65.70 9/19/2017 Outperform 5Y $0.60 +428.24% +67.63% +360.61 0 Comment
mathieugp 24.23 9/28/2009 Underperform 3M $7.87 -59.59% +299.69% +359.28 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.